| 臺大學術典藏 |
2022-03-14T23:45:40Z |
Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients
|
PO-HAN LIN; Chen, Shin Cheh; Tseng, Ling Ming; Chang, King Jen; Huang, Ai Chu; Cheng, Kuo Chih; Yang, Karen; Wu, Hui Chen; Chao, Tsu Yi; Chang, Yuan Ching; Lin, Peng Chan; WEN-HUNG KUO; Kuo, Wen Lin; CHING-HUNG LIN; Chen, Huo Mu; Yeh, Dah Cherng; Liu, Liang Chih; Liu, Chun Yu; Wang, Ming Yang; Lo, Chiao; YEN-SHEN LU; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2022-03-10T02:31:42Z |
Cisplatin as an active treatment in zoledronate-refractory hypercalcemia
|
PO-HAN LIN; Chiu C.-F.; Lu Y.-S. |
| 臺大學術典藏 |
2022-03-10T02:31:42Z |
Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulation
|
PO-HAN LIN; Lu Y.-S.; Lin C.-H.; Chang D.-Y.; Huang C.-S.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-10T02:31:42Z |
Acute Q fever presenting as fever of unknown origin with rapidly progressive hepatic failure in a patient with alcoholism
|
PO-HAN LIN; Lo Y.-C.; Chiang F.-T.; Wang J.-L.; Jeng Y.-M.; Fang C.-T.; Chang S.-C. |
| 臺大學術典藏 |
2022-03-10T02:31:41Z |
Evaluation of breast cancer susceptibility loci on 2q35, 3p24, 17q23 and FGFR2 genes in Taiwanese women with breast cancer
|
Lin C.-Y.; Ho C.-M.; Bau D.-T.; Yang S.-F.; Liu S.-H.; PO-HAN LIN; Lin T.-H.; Tien N.; Shih M.-C.; Lu J.-J. |
| 臺大學術典藏 |
2022-03-10T02:31:41Z |
Novel heterozygous tissue-nonspecific alkaline phosphatase (TNAP) gene mutations causing lethal perinatal hypophosphatasia
|
Chang K.-C.; PO-HAN LIN; Su Y.-N.; Peng S.S.-F.; Lee N.-C.; Chou H.-C.; Chen C.-Y.; Hsieh W.-S.; Tsao P.-N. |
| 臺大學術典藏 |
2022-03-10T02:31:41Z |
Prognostic molecular markers in Women aged 35 years or younger with breast cancer: Is there a difference from the older patients?
|
Lin C.-H.; Lu Y.-S.; Huang C.-S.; Kuo K.-T.; Wang C.-C.; You S.-L.; PO-HAN LIN; Chang D.-Y.; Kuo W.-H.; Chang K.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2022-03-10T02:31:40Z |
Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer
|
Kuo W.-H.; PO-HAN LIN; Huang A.-C.; Chien Y.-H.; Liu T.-P.; Lu Y.-S.; Bai L.-Y.; Sargeant A.M.; Lin C.-H.; Cheng A.-L.; Hsieh F.-J.; Hwu W.-L.; Chang K.-J. |
| 臺大學術典藏 |
2022-03-10T02:31:40Z |
Prognostic impact of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with internal tandem duplication of FLT3
|
PO-HAN LIN; Lin C.-C.; Yang H.-I.; Li L.-Y.; Bai L.-Y.; Chiu C.-F.; Liao Y.-M.; Lin C.-Y.; Hsieh C.-Y.; Lin C.-Y.; Ho C.-M.; Yang S.-F.; Peng C.-T.; Tsai F.-J.; Yeh S.-P. |
| 臺大學術典藏 |
2022-03-10T02:31:39Z |
Prognostic analysis of adjuvant chemotherapy in patients with nasopharyngeal carcinoma
|
Lin C.-C.; Chen T.-T.; Lin C.-Y.; Hsieh C.-Y.; PO-HAN LIN; Chien C.-R.; Chiu C.-F.; Yeh S.-P. |
| 臺大學術典藏 |
2022-03-10T02:31:39Z |
Clinical and pathologic risk factors of tumor recurrence in patients with node-negative early breast cancer after mastectomy
|
PO-HAN LIN; Yeh M.-H.; Liu L.-C.; Chen C.-J.; Tsui Y.-C.; Su C.-H.; Wang H.-C.; Liang J.-A.; Chang H.-W.; Wu H.-S.; Yeh S.-P.; Li L.-Y.; Chiu C.-F. |
| 臺大學術典藏 |
2022-03-10T02:31:39Z |
OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosis
|
Bai L.-Y.; Weng J.-R.; Chiu C.-F.; Wu C.-Y.; Yeh S.-P.; Sargeant A.M.; PO-HAN LIN; Liao Y.-M. |
| 臺大學術典藏 |
2022-03-10T02:31:38Z |
Palonosetron and dexamethasone for the prevention of nausea and vomiting in patients receiving allogeneic hematopoietic stem cell transplantation
|
Yeh S.-P.; Lo W.-C.; Hsieh C.-Y.; Bai L.-Y.; Lin C.-C.; PO-HAN LIN; Lin C.-Y.; Liao Y.-M.; Chiu C.-F. |
| 臺大學術典藏 |
2022-03-10T02:31:38Z |
Safety and efficacy of pegylated liposomal doxorubicinbased adjuvant chemotherapy in patients with stage I-III triple-negative breast cancer
|
Lien M.-Y.; Liu L.-C.; Wang H.-C.; Yeh M.-H.; Chen C.-J.; Yeh S.-P.; Bai L.-Y.; Liao Y.-M.; Lin C.-Y.; Hsieh C.-Y.; Lin C.-C.; Li L.-Y.; PO-HAN LIN; Chiu C.-F. |
| 臺大學術典藏 |
2022-03-10T02:31:38Z |
Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer
|
PO-HAN LIN; Kuo W.-H.; Huang A.-C.; Lu Y.-S.; Lin C.-H.; Kuo S.-H.; Wang M.-Y.; Liu C.-Y.; Cheng F.T.-F.; Yeh M.-H.; Li H.-Y.; Yang Y.-H.; Hsu Y.-H.; Fan S.-C.; Li L.-Y.; Yu S.-L.; Chang K.-J.; Chen P.-L.; Ni Y.-H.; Huang C.-S. |
| 臺大學術典藏 |
2022-03-10T02:31:37Z |
Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer
|
Kuo S.-H.; Yang S.-Y.; You S.-L.; Lien H.-C.; Lin C.-H.; PO-HAN LIN; Huang C.-S. |
| 臺大學術典藏 |
2022-03-10T02:31:37Z |
Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors
|
Chou W.-C.; PO-HAN LIN; Yeh Y.-C.; Shyr Y.-M.; Fang W.-L.; Wang S.-E.; Liu C.-Y.; Chang P.M.-H.; Chen M.-H.; Hung Y.-P.; Li C.-P.; Chao Y.; Chen M.-H. |
| 臺大學術典藏 |
2022-03-10T02:31:36Z |
Rapid detection of BRCA1/2 recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panels
|
Kwong A.; Ho J.C.W.; Shin V.Y.; Kurian A.W.; Tai E.; Esserman L.J.; Weitzel J.N.; PO-HAN LIN; Field M.; Domchek S.M.; Lo J.; Ngan H.Y.S.; Ma E.S.K.; Chan T.L.; Ford J.M. |
| 臺大學術典藏 |
2022-03-10T02:31:36Z |
Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells
|
Liu C.-Y.; Lau K.-Y.; Hsu C.-C.; Chen J.-L.; Lee C.-H.; Huang T.-T.; Chen Y.-T.; Huang C.-T.; PO-HAN LIN; Tseng L.-M. |
| 臺大學術典藏 |
2022-03-10T02:31:36Z |
A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice
|
PO-HAN LIN; Li H.-Y.; Fan S.-C.; Yuan T.-H.; Chen M.; Hsu Y.-H.; Yang Y.-H.; Li L.-Y.; Yeh S.-P.; Bai L.-Y.; Liao Y.-M.; Lin C.-Y.; Hsieh C.-Y.; Lin C.-C.; Lin C.-H.; Lien M.-Y.; Chen T.-T.; Ni Y.-H.; Chiu C.-F. |
| 臺大學術典藏 |
2022-03-10T02:31:35Z |
Using next-generation sequencing to redefine BRCAness in triple-negative breast cancer
|
PO-HAN LIN; Chen M.; Tsai L.-W.; Lo C.; Yen T.-C.; Huang T.Y.; Chen C.-K.; Fan S.-C.; Kuo S.-H.; Huang C.-S. |
| 臺大學術典藏 |
2022-03-10T02:31:35Z |
Varlitinib downregulates HER/ERK signaling and induces apoptosis in triple negative breast cancer cells
|
Liu C.-Y.; Chu P.-Y.; Huang C.-T.; Chen J.-L.; Yang H.-P.; Wang W.-L.; Lau K.-Y.; Lee C.-H.; Lan T.-Y.; Huang T.-T.; PO-HAN LIN; Dai M.-S.; Tseng L.-M. |
| 臺大學術典藏 |
2022-03-10T02:31:35Z |
A dna damage response gene panel for different histologic types of epithelial ovarian carcinomas and their outcomes
|
Chiang Y.-C.; PO-HAN LIN; Lu T.-P.; Kuo K.-T.; Tai Y.-J.; Hsu H.-C.; Wu C.-Y.; Lee C.-Y.; Shen H.; Chen C.-A.; Cheng W.-F. |
| 臺大學術典藏 |
2022-03-10T02:31:34Z |
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
|
PO-HAN LIN; Wang M.-Y.; Lo C.; Tsai L.-W.; Yen T.-C.; Huang T.Y.; Huang W.-C.; Yang K.; Chen C.-K.; Fan S.-C.; Kuo S.-H.; Huang C.-S. |
| 臺大學術典藏 |
2022-03-10T02:31:34Z |
Homologous Recombination Deficiency Assays in Epithelial Ovarian Cancer: Current Status and Future Direction
|
Chiang Y.-C.; PO-HAN LIN; Cheng W.-F. |
